Related Experiment Videos
Summary
Pyrazolone intoxication in children can cause severe symptoms, including coma and cardiac arrest. Hemoperfusion is a promising therapy to reduce the body
Area of Science:
- Toxicology
- Pediatrics
- Pharmacology
Background:
- Pyrazolone derivatives are commonly used analgesics and antipyretics.
- Severe or fatal intoxications in children due to pyrazolones have been reported, often accidental.
- Characteristic symptoms include altered consciousness, convulsions, apnea, and cardiac arrest, with potential hepatic lesions.
Purpose of the Study:
- To review reported cases of pyrazolone intoxication in children.
- To evaluate the potential efficacy of hemoperfusion as a treatment for pyrazolone poisoning.
Main Methods:
- Review of German literature over 59 years for severe or fatal pyrazolone intoxications in children.
- Analysis of pharmacokinetic data (distribution volumes, plasma half-lives, clearances) and in vitro removal kinetics of various pyrazolones.
- Assessment of hemoperfusion as a method to reduce systemic drug load.
Main Results:
- Approximately 50 severe or fatal cases of pyrazolone intoxication in children were identified.
- Hemoperfusion is suggested as the sole effective measure to significantly reduce the total body load of pyrazolones.
- In vitro data for aminophenazone, propyphenazone, metamizole, phenylbutazone, and oxyphenbutazone support the efficacy of hemoperfusion with amberlite XAD-4 resin.
Conclusions:
- Pyrazolone poisoning in children can lead to severe and life-threatening complications.
- Hemoperfusion, particularly with amberlite XAD-4 resin, shows potential as an effective treatment to enhance the clearance of pyrazolones.
- Further clinical data is needed to confirm the efficacy of hemoperfusion in managing pyrazolone poisoning in pediatric patients.